“In Silico Evaluation of Bioactive Compounds from Caesalpinia sappan L. as Lipase and Penicillin-Binding Protein Inhibitors for Antibacterial Therapy” (2026) Pharmaceutical Reports, 5(1). doi:10.33096/pharmrep.v5i1.404.